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Abstract
Introduction: Chordomas are rare tumors of the skeletal system that arise from an intra-osseous benign precursor
of notochordal cells. They are mainly locally aggressive. However, metastases to other sites, including the humeri,
resulting in pathological fractures have been reported. We report the case of a patient with a metastatic chordoma
that produced a pathologic fracture of the humerus.
Case presentation: We report the case of a 60-year-old Iranian woman who presented with a fracture of her right
humerus following a minor trauma. She had a history of a sacrococcygeal chordoma. Histological and
immunohistochemical studies of the fracture site suggested the diagnosis of a chordoma.
Conclusions: Chordoma is a rare tumor and rarely metastasizes, but it should be considered in the differential
diagnosis of epithelioid bone tumors. The only current effective treatment for this type of tumor is carbon ion
therapy. There is currently no effective medical therapy available for advanced chordoma, and this type of tumor is
not very responsive to radiotherapy.
Introduction
Chordomas are rare, low-grade, primary malignant bone
tumors arising from primitive notochord remnants of
the axial skeleton. The sacrum is the most common
anatomical site of origin, accounting for 50% to 60% of
all cases, followed by the skull base region (spheno-occi-
pital and/or nasal), accounting for 25% to 35% of cases;
the cervical vertebrae, accounting for approximately 10%
of cases; and the thoracolumbar vertebrae, accounting
for approximately 5% of cases [1-4].
These tumors are mainly locally aggressive, with a
high incidence of local recurrence and a poor long-term
prognosis. Metastatic lesions have been reported in the
liver, lungs, lymph nodes, peritoneum, skin, heart,
humeri, brain, and distant regions of the spine [1-7].
Case presentation
A 60-year-old Iranian woman presented to our hospital
with pain and swelling in her right arm following a
minor fall. Our initial physical examination revealed her
to be in a good general condition. She was normoten-
sive, with a pulse rate of 92 beats/minute. Her other
laboratory values were as follows: body temperature 37°
C, hemoglobin 12.2 g/dL, leukocytes 22 cells/mm
3,p l a -
telets 200 U/L, sodium 141 mEq/L, potassium 4 mEq/L,
glucose 11.6 mmol/L, blood urea nitrogen 15.1 mmol/L,
and creatinine 250 mmol/L. A plain X-ray showed a
pathologic fracture in the mid-shaft of her right
humerus and a large, ill-defined soft tissue mass (Figure
1). Magnetic resonance imaging (MRI) showed a huge
lobulated mass destroying the shaft of the humerus and
displacing the surrounding soft tissue. The mass was
bright on serial T2-weighted MRI scans and dark on
serial T1-weighted MRI scans, with marked enhance-
ment after a gadolinium injection (Figure 2). Four years
ago she had been treated for a sacrococcygeal chordoma
with surgical resection and post-operative radiotherapy.
A local tumor recurrence developed after one year and
required additional surgical procedures. A histological
examination of the biopsy from the humeral lesion
showed a lobulated mass composed of cuboidal to poly-
gonal cells with eccentric nuclei, clear to eosinophilic
cytoplasm, and pools of extracellular mucin (arrow in
Figure 3). Typically, few tumor cells have a “physalifer-
ous” (bubble-bearing) appearance. On the basis of these
findings, we considered differential diagnoses such as
myxoid chondrosarcoma, myxoid liposarcoma, primary
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adenoma of the salivary gland, metastatic renal cell car-
cinoma (RCC), or metastatic carcinoma with intra-cyto-
plasmic mucin from the colon or lung [8,9]. Most
metastatic carcinomas have more of the cytological fea-
tures of malignancy than chordomas do. The tumor
cells stained positive for AE1/3 (Figure 4), ethidium
monoazide (EMA), S100, and vimentin. Although both
chordomas and chondrosarcomas stain with S100 pro-
tein, myxoid chondrosarcomas do not stain with keratin
and EMA. Additional immunochemistry was performed
for CD10, the results of which were negative in this case
and usually expressed in RCC. Abdominal and pelvic
ultrasonography and computed tomography (CT) of her
chest and abdomen were normal. On the basis of this
evidence and our review of the original histology follow-
ing her previous chordoma excision (which was histolo-
gically identical to the humeral lesion), a diagnosis of
Figure 2 Magnetic resonance imaging scan showing extensive
soft tissue mass with bone destruction of the left humerus.
Figure 1 Plain radiograph showing a tumor characterized by a
fracture in the mid-shaft of the right humerus with a large soft
tissue mass.
Figure 3 Typical lobulated appearance of a chordoma with
small nests of tumor cells on a pale blue myxoid background.
Prominent intra-cytoplasmic vacuolization can be seen (arrow)
(hematoxylin and eosin stain, ×100).
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active treatment.
Discussion
Chordomas arise from the remnant of the fetal noto-
chord and grow slowly. The most common location is
the sacrococcygeal region. This tumor is generally
reported in adults; most patients are in the fifth to
seventh decades of life [10-12]. Classic radiological find-
i n g sf o rc h o r d o m aa r eab o n yl y t i cl e s i o nw i t ha n
accompanying soft tissue mass. The sacrococcygeal
lesions are known to metastasize more frequently than
the other types, and radiation therapy raises the risk of
metastasis. Despite all the available modalities of treat-
ment, the prognosis for this condition remains poor
because of the difficulty in gaining surgical clearance
and the tumor’s propensity to metastasize [11]. Histolo-
gically, mitoses and anaplasia can be present in chordo-
mas without adversely affecting the duration of a
patient’s survival. Previous studies have found that many
of the metastatic lesions were asymptomatic or were
found during post-mortem examination, which suggests
that metastases from chordomas could be considered
indolent in these cases [4,5]. Our patient had an asymp-
tomatic rib lesion as well as a large humeral metastasis
with pathologic fracture. A pathological analysis of the
metastatic tumor revealed features identical to the pri-
mary tumor. Metastasis to the long bones is a rare
phenomenon.
The biological behavior of chordomas differs from
patient to patient. Some patients harbor tumors capable
of aggressive behavior both locally and distantly, while
others have tumors that behave more indolently. There
is no good method for predicting the behavior of
individual chordomas [4,11]. Therefore, it seems that
aggressive surgical resection with local adjuvant treat-
ment, such as carbon ion therapy, must be undertaken
to prevent the development of recurrent lesions and
metastatic neoplasms.
Conclusions
Chordomas are rare tumors. They are relatively radiore-
sistant, and currently there is no effective medical ther-
apy for treating them. Complete local excision is the
most effective treatment for achieving a long-term cure.
Although these tumors rarely metastasize, they need to
be considered in the differential diagnosis of metastatic
epithelioid bone tumors.
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